These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

36 related articles for article (PubMed ID: 33421520)

  • 21. Plant-produced chimeric virus-like particles - a new generation vaccine against African horse sickness.
    Rutkowska DA; Mokoena NB; Tsekoa TL; Dibakwane VS; O'Kennedy MM
    BMC Vet Res; 2019 Dec; 15(1):432. PubMed ID: 31796116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunogenic profile of a plant-produced nonavalent African horse sickness viral protein 2 (VP2) vaccine in IFNAR-/- mice.
    O'Kennedy MM; Roth R; Ebersohn K; du Plessis LH; Mamputha S; Rutkowska DA; du Preez I; Verschoor JA; Lemmer Y
    PLoS One; 2024; 19(4):e0301340. PubMed ID: 38625924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. African horsesickness virus VP7 sub-unit vaccine protects mice against a lethal, heterologous serotype challenge.
    Wade-Evans AM; Pullen L; Hamblin C; O'Hara R; Burroughs JN; Mertens PP
    J Gen Virol; 1997 Jul; 78 ( Pt 7)():1611-6. PubMed ID: 9225037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The immunogenicity of recombinant vaccines based on modified Vaccinia Ankara (MVA) viruses expressing African horse sickness virus VP2 antigens depends on the levels of expressed VP2 protein delivered to the host.
    Calvo-Pinilla E; Gubbins S; Mertens P; Ortego J; Castillo-Olivares J
    Antiviral Res; 2018 Jun; 154():132-139. PubMed ID: 29678552
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Potential of Plant-Produced Virus-like Particle Vaccines for African Horse Sickness and Other Equine Orbiviruses.
    Pitchers KG; Boakye OD; Campeotto I; Daly JM
    Pathogens; 2024 May; 13(6):. PubMed ID: 38921755
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Humoral and cell-mediated immune responses to plant-produced African horse sickness virus VP7 quasi-crystals.
    Fearon SH; Dennis SJ; Hitzeroth II; Rybicki EP; Meyers AE
    Virus Res; 2021 Mar; 294():198284. PubMed ID: 33421520
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reverse genetics approaches: a novel strategy for African horse sickness virus vaccine design.
    Calvo-Pinilla E; Marín-López A; Utrilla-Trigo S; Jiménez-Cabello L; Ortego J
    Curr Opin Virol; 2020 Oct; 44():49-56. PubMed ID: 32659516
    [TBL] [Abstract][Full Text] [Related]  

  • 28. African Horse Sickness: A Review of Current Understanding and Vaccine Development.
    Dennis SJ; Meyers AE; Hitzeroth II; Rybicki EP
    Viruses; 2019 Sep; 11(9):. PubMed ID: 31514299
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Future international management of African horse sickness vaccines.
    House JA
    Arch Virol Suppl; 1998; 14():297-304. PubMed ID: 9785514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. African horse sickness virus structure.
    Roy P; Mertens PP; Casal I
    Comp Immunol Microbiol Infect Dis; 1994; 17(3-4):243-73. PubMed ID: 8001348
    [TBL] [Abstract][Full Text] [Related]  

  • 31. African horse sickness.
    Zientara S; Weyer CT; Lecollinet S
    Rev Sci Tech; 2015 Aug; 34(2):315-27. PubMed ID: 26601437
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.